Tumor infiltrating lymphocytes in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of published randomized clinical trials

被引：0
|
作者：
Solinas, C. [1 ]
Ceppi, M. [2 ]
Lambertini, M. [3 ]
Scartozzi, M. [4 ]
Garaud, S. [5 ]
Fumagalli, D. [6 ]
De Azambuja, E. [7 ]
Salgado, R. [8 ]
Willard-Gallo, K. [5 ]
Ignatiadis, M. [9 ]
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Mol Immunol Unit, Brussels, Belgium
[2] IRCCS AOU San Martino IST, Unit Clin Epidemiol, Genoa, Italy
[3] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium
[4] Univ Cagliari, Med Oncol, Cagliari, Italy
[5] Inst Jules Bordet, Mol Immunol Unit, Brussels, Belgium
[6] Breast Int Grp, Brussels, Belgium
[7] Univ Libre Bruxelles, Inst Jules Bordet, BrREAST Data Ctr, Brussels, Belgium
[8] GZA Ziekenhuizen, Dept Pathol, Sint Augustinus Campus, Antwerp, Belgium
[9] Univ Libre Bruxelles, Inst Jules Bordet, Acad Trials Promoting Unit, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
27P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer
    Heppner, Barbara Ingold
    Untch, Michael
    Denkert, Carsten
    Pfitzner, Berit M.
    Lederer, Bianca
    Schmitt, Wolfgang
    Eidtmann, Holger
    Fasching, Peter A.
    Tesch, Hans
    Solbach, Christine
    Rezai, Mahdi
    Zahm, Dirk M.
    Holms, Frank
    Glados, Manfred
    Krabisch, Petra
    Heck, Esther
    Ober, Angelika
    Lorenz, Petra
    Diebold, Kurt
    Habeck, Jorg-Olaf
    Loib, Sibylle
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (23) : 5747 - 5754
  • [32] Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy
    Liu, Shiwei
    Duan, Xuening
    Xu, Ling
    Xin, Ling
    Cheng, Yuanjia
    Liu, Qian
    Ye, Jingming
    Zhang, Shuang
    Zhang, Hong
    Zhu, Sainan
    Li, Ting
    Liu, Yinhua
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (02) : 239 - 249
  • [33] Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy
    Shiwei Liu
    Xuening Duan
    Ling Xu
    Ling Xin
    Yuanjia Cheng
    Qian Liu
    Jingming Ye
    Shuang Zhang
    Hong Zhang
    Sainan Zhu
    Ting Li
    Yinhua Liu
    [J]. Breast Cancer Research and Treatment, 2015, 154 : 239 - 249
  • [34] Predictive value of stromal tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant chemotherapy: A meta-analysis
    Xia, Guangfa
    Zhang, Ziran
    Jiang, Qin
    Wang, Huan
    Wang, Jie
    [J]. MEDICINE, 2024, 103 (06) : E36810
  • [35] Relationship between HER-2 amplification and tumor infiltrating lymphocytes in breast cancer patients treated with neoadjuvant trastuzumab
    Masini, C.
    Bisagni, G.
    Ragazzi, M.
    Bisagni, A.
    Dallaglio, K.
    Falco, G.
    Ferrari, G.
    Bassano, C.
    Gardini, G.
    Bologna, A.
    Moretti, G.
    Boni, C.
    Baldi, L.
    Pinto, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [36] Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
    Yuan, Ye
    Liu, Xumei
    Cai, Yi
    Li, Wenyuan
    [J]. SYSTEMATIC REVIEWS, 2022, 11 (01)
  • [37] Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
    Ye Yuan
    Xumei Liu
    Yi Cai
    Wenyuan Li
    [J]. Systematic Reviews, 11
  • [38] Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial)
    Guarneri, Valentina
    Frassoldati, Antonio
    Piacentini, Federico
    Jovic, Gordana
    Giovannelli, Simona
    Oliva, Cristina
    Conte, PierFranco
    [J]. CLINICAL BREAST CANCER, 2008, 8 (02) : 192 - 194
  • [39] Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for HER2-positive breast cancer: a prospective cohort study
    Liu, Lu
    Zhu, Mingzhi
    Wang, Yanyan
    Li, Muhan
    Gu, Yuanting
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [40] Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for HER2-positive breast cancer: a prospective cohort study
    Lu Liu
    Mingzhi Zhu
    Yanyan Wang
    Muhan Li
    Yuanting Gu
    [J]. World Journal of Surgical Oncology, 21
12345